NORFLOXACIN RESISTANCE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI

被引:66
作者
AOYAMA, H [1 ]
SATO, K [1 ]
KATO, T [1 ]
HIRAI, K [1 ]
MITSUHASHI, S [1 ]
机构
[1] KYORIN PHARMACEUT CO LTD,CENT RES LABS,NOGI,TOCHIGI,JAPAN
关键词
D O I
10.1128/AAC.31.10.1640
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1640 / 1641
页数:2
相关论文
共 14 条
[1]   STUDIES ON MECHANISM OF ACTION OF NALIDIXIC-ACID [J].
BOURGUIG.GJ ;
LEVITT, M ;
STERNGLA.R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 4 (04) :479-486
[2]  
BRENNER DJ, 1984, BERGEYS MANUAL SYSTE, V1, P408
[3]   DNA GYRASE - PURIFICATION AND CATALYTIC PROPERTIES OF A FRAGMENT OF GYRASE-B PROTEIN [J].
GELLERT, M ;
FISHER, LM ;
ODEA, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (12) :6289-6293
[4]   NALIDIXIC-ACID RESISTANCE - 2ND GENETIC CHARACTER INVOLVED IN DNA GYRASE ACTIVITY [J].
GELLERT, M ;
MIZUUCHI, K ;
ODEA, MH ;
ITOH, T ;
TOMIZAWA, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (11) :4772-4776
[5]   ESCHERICHIA COLI K-12 MUTANTS RESISTANT TO NALIDIXIC ACID - GENETIC MAPPING AND DOMINANCE STUDIES [J].
HANE, MW ;
WOOD, TH .
JOURNAL OF BACTERIOLOGY, 1969, 99 (01) :238-&
[6]   DIFFERENCES IN SUSCEPTIBILITY TO QUINOLONES OF OUTER-MEMBRANE MUTANTS OF SALMONELLA-TYPHIMURIUM AND ESCHERICHIA-COLI [J].
HIRAI, K ;
AOYAMA, H ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :535-538
[7]   ISOLATION AND CHARACTERIZATION OF NORFLOXACIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI K-12 [J].
HIRAI, K ;
AOYAMA, H ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :248-253
[8]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
TUNG, C ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644
[9]  
INOUE M, 1986, CIPROFLOXACIN ANTIMI, P19
[10]   EMERGENCE OF RESISTANCE TO BETA-LACTAMS, AMINOGLYCOSIDES, AND QUINOLONES DURING COMBINATION THERAPY FOR INFECTION DUE TO SERRATIA-MARCESCENS [J].
SANDERS, CC ;
WATANAKUNAKORN, C .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :617-619